In 1992, 150 nations signed the Convention on Biological Diversity (CBD) at the Rio Earth Summit. Then, in 2014, the United Nations’s Nagoya Protocol on Access and Benefit Sharing (ABS) entered into force as a supplementary agreement to the CBD. The objective of the Nagoya Protocol is to help conserve our biodiversity by sharing the benefits from its utilization in a fair and equitable way. The protocol allows for the tracking of genetic resources such as active ingredients used in R&D from provider to user all the way to innovation and potential commercialization. 104 countries have ratified the Nagoya Protocol, and so far there are more than 15 country-specific regulations, including the EU 511/2014 due diligence regulation.
Help your company meet the ABS obligations
The Nagoya Protocol applies to a variety of sectors including the pharmaceutical, biotechnology, food and cosmetics industries.
As an expert in traceability software solutions, ChainPoint can help your company meet its ABS track and trace obligations by among others:
- automating the collection of information related to compliance along the supply chains of your natural ingredients
- alerting you of potential non-compliance risks
- automatically generating pre-filled declaration template.
For more information on how ChainPoint and its partners can help, please contact us.
Watch this video for more information on ABS